Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Infections, Monkeypox virus medication

Emerging viruses and current strategies for vaccine intervention – Inactivated viruses

Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201) – Discussion

Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses – Effects mDEF201 Prophylaxis Delivered via Nasal Sinus or Lung on Vaccinia Virus Systemic Infections

Rapid and High-Throughput pan-Orthopoxvirus Detection and Identification using PCR and Mass Spectrometry – Viral isolates and DNA extraction

Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses – Ethics Statement

Emerging viruses and current strategies for vaccine intervention – Synthetic peptides

Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201) – Therapy of infection with mDEF201

Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents – Discussion

Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents – Antiviral Protection in Small Animals Challenged With Monkeypox Virus

Rapid and High-Throughput pan-Orthopoxvirus Detection and Identification using PCR and Mass Spectrometry – Rabbitpox virus-infected rabbits

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications – 5. Conclusions

Infectious Disease Risk Across the Growing Human-Non Human Primate Interface: A Review of the Evidence – Conflict of Interest

The Application of Genomics to Emerging Zoonotic Viral Diseases – Challenges for the Future

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications – 3.2. Immunogenicity

Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus – Introduction

Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa – The potentialities of emerging zoonotic diseases from wild to domestic environments

Infectious Disease Risk Across the Growing Human-Non Human Primate Interface: A Review of the Evidence – Discussion

The Application of Genomics to Emerging Zoonotic Viral Diseases – Emerging Zoonotic Viruses

Spillover and pandemic properties of zoonotic viruses with high host plasticity – Additional Information

Spillover and pandemic properties of zoonotic viruses with high host plasticity – Results

Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses – Background

Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus – Uncertainty in the Case Detection Rate and Overdispersion Parameter

Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses – Virulence of WR and Wyeth strains by intranasal infection

A New Approach for Monitoring Ebolavirus in Wild Great Apes – Introduction

Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa – Conclusion